在P2X3中的第二个药物结合点
Trung Thach1, KanagaVijayan Dhanabalan1, Prajwal Prabhakarrao Nandekar2
1Department of Biological Sciences, Purdue University, West Lafayette, IN-47907, USA.
研究人员阐明了与camlipixant结合的P2X3受体的结构,揭示了一个新的全抑制机制. 这一发现促进了对慢性咳治疗方法和P2X3受体对抗性的理解.
科学领域:
- 结构生物学 结构生物学
- 药理学 药理学是指药理学的学科.
- 分子神经科学 分子神经科学
背景情况:
- 纯能P2X3受体对慢性咳至关重要,影响超过10%的人口.
- 开发选择性P2X3抗剂是具有挑战性的,因为保留了受体结构.
- 坎利皮克桑在临床试验的后期阶段是一个有前途的P2X3抗剂,但其精确的结合和抑制机制是未知的.
研究的目的:
- 为了确定与camlipixant复合的P2X3受体的高分辨率结构.
- 为了阐明P2X3受体对抗性和camlipixant的全抑制的分子机制.
- 了解卡姆利皮克桑特对其他P2X受体家族成员的选择性的结构基础.
主要方法:
- 建立了一个表达同位三元P2X3受体的稳定细胞系.
- 使用基架净化了P2X3-camlipixant复合体.
- 通过冷电子显微镜 (cryo-EM) 确定了复合物的结构.
- 进行结构-活动关系研究,分子建模和模拟.
主要成果:
- 揭示了camlipixant的P2X3受体上一个以前未知的药物结合部位.
- 证明卡姆利皮克桑作为P2X3.3的全抑制剂起作用.
- 确定了负责卡姆利皮克桑特选择性P2X3对抗性的关键结构特征.
结论:
- 这项研究为camlipixant的P2X3受体对抗提供了第一个结构性见解.
- 卡姆利皮克桑的全抑制机制和选择性结合部位为P2X3向提供了新的理解.
- 这些发现为改善慢性咳和相关疾病的药物设计铺平了道路.
更多相关视频
08:33Measuring Nucleotide Binding to Intact, Functional Membrane Proteins in Real Time
Published on: March 11, 2021
11:47Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells
Published on: April 3, 2019
相关概念视频
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
GPCR Desensitization
Ligand Binding and Linkage
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
